Johns Hopkins University School of Medicine Researcher Has Provided New Data on Carcinomas (Immunomodulatory response to neoadjuvant nivolumab in non-metastatic clear cell renal cell carcinoma)

Press/Media

Period5 Apr 2023

Media coverage

1

Media coverage